Glioma-Initiating Cell Elimination by Metformin Activation of FOXO3 via AMPK
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glioma-Initiating Cell Elimination by Metformin Activation of FOXO3 via AMPK
Authors
Keywords
-
Journal
Stem Cells Translational Medicine
Volume 1, Issue 11, Pages 811-824
Publisher
Wiley
Online
2012-11-16
DOI
10.5966/sctm.2012-0058
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide
- (2014) Krzysztof Łabuzek et al. Pharmacological Reports
- Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types
- (2011) D. Iliopoulos et al. CANCER RESEARCH
- Glioblastoma stem cells
- (2011) Ghazaleh Tabatabai et al. CELL AND TISSUE RESEARCH
- The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
- (2011) Maria M. Mihaylova et al. NATURE CELL BIOLOGY
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- Metformin and neoplasia: Implications and indications
- (2011) Ahmad Aljada et al. PHARMACOLOGY & THERAPEUTICS
- MEK-ERK Signaling Dictates DNA-Repair Gene MGMT Expression and Temozolomide Resistance of Stem-Like Glioblastoma Cells via the MDM2-p53 Axis
- (2011) Atsushi Sato et al. STEM CELLS
- Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway
- (2010) Xinguo Hou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Potential therapeutic implications of cancer stem cells in glioblastoma
- (2010) Lin Cheng et al. BIOCHEMICAL PHARMACOLOGY
- The AMPK-FoxO3A axis as a target for cancer treatment
- (2010) Fulvio Chiacchiera et al. CELL CYCLE
- Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK Activation
- (2010) Simon A. Hawley et al. Cell Metabolism
- Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner
- (2010) Adem Kalender et al. Cell Metabolism
- The therapeutic promise of the cancer stem cell concept
- (2010) Natasha Y. Frank et al. JOURNAL OF CLINICAL INVESTIGATION
- Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?
- (2010) I. Ben Sahra et al. MOLECULAR CANCER THERAPEUTICS
- Seeing is Believing: Are Cancer Stem Cells the Loch Ness Monster of Tumor Biology?
- (2010) Justin D. Lathia et al. Stem Cell Reviews and Reports
- Crosstalk Between the PI3K/mTOR and MEK/ERK Pathways Involved in the Maintenance of Self-Renewal and Tumorigenicity of Glioblastoma Stem-Like Cells
- (2010) Jun Sunayama et al. STEM CELLS
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
- (2009) Mark Shackleton et al. CELL
- In vivo assessment of high-grade glioma biochemistry using microdialysis: a study of energy-related molecules, growth factors and cytokines
- (2009) Hani J. Marcus et al. JOURNAL OF NEURO-ONCOLOGY
- AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
- (2009) Carles Cantó et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started